Inclisiran lowers low-density lipoprotein (LDL; ‘bad’) cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol.
Inclisiran lowers low-density lipoprotein (LDL; ‘bad’) cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol.